Vagus somatosensory evoked potentials - A possibility for diagnostic improvement in patients with mild cognitive impairment?

Dementia and Geriatric Cognitive Disorders

Volumn 33, Issue 5, 2012, Pages 289-296

  Metzger, Florian G ^a   Polak, Thomas ^c   Aghazadeh, Yashar ^d   Ehlis, Ann Christine ^a   Hagen, Katja ^b   Fallgatter, Andreas J ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d Northwest Hospital   (Germany)

Author keywords

Alzheimer's disease; Brainstem; Mild cognitive impairment; Vagus somatosensory evoked potentials

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HUMAN; LATENT PERIOD; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; VAGUS EVOKED SOMATOSENSORY RESPONSE; VAGUS NERVE STIMULATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN STEM; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; VAGUS NERVE;

EID: 84863113572     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000339359     Document Type: Article

References (31)

1. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001;58: 1985-1992
2. Petersen RC, Morris JC: Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005;62:1160-1163, discussion 1167
3. Petersen RC, Negash S: Mild cognitive impairment: An overview. CNS Spectr 2008;13: 45-53
4. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308
5. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST: Practice parameter: early detection of dementia: mild cognitive impairment (an evidence- based review)-report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56: 1133-1142
6. Gainotti G: Origins, controversies and recent developments of the MCI construct. Curr Alzheimer Res 2010;7:271-279
7. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259
8. Parvizi J, Van Hoesen GW, Damasio A: The selective vulnerability of brainstem nuclei to Alzheimer's disease. Ann Neurol 2001;49: 53-66
9. Curcio CA, Kemper T: Nucleus raphe dorsalis in dementia of the Alzheimer type: Neurofibrillary changes and neuronal packing density. J Neuropathol Exp Neurol 1984;43: 359-368
10. Yamamoto T, Hirano A: Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons. Ann Neurol 1985;17:573-577
11. Aletrino MA, Vogels OJ, Van Domburg PH, Ten Donkelaar HJ: Cell loss in the nucleus raphes dorsalis in Alzheimer's disease. Neurobiol Aging 1992;13:461-468
12. Halliday GM, McCann HL, Pamphlett R, Brooks WS, Creasey H, McCusker E, Cotton RG, Broe GA, Harper CG: Brain stem serotonin- synthesizing neurons in Alzheimer's disease: A clinicopathological correlation. Acta Neuropathol 1992;84:638-650
13. German DC, White CL, Sparkman DR: Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience 1987;21:305-312
14. Hertz L: Is Alzheimer's disease an anterograde degeneration, originating in the brainstem, and disrupting metabolic and functional interactions between neurons and glial cells? Brain Res Brain Res Rev 1989;14: 335-353
15. Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, Hof PR: Does Alzheimer's disease begin in the brainstem? Neuropathol Appl Neurobiol 2009;35: 532-554
16. Wilcock GK, Esiri MM, Bowen DM, Hughes AO: The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type. J Neurol Neurosurg Psychiatry 1988;51:842-849
17. Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL: The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 1988;24:233-242
18. Toledo MA, Junqueira LF Jr: Cardiac autonomic modulation and cognitive status in Alzheimer's disease. Clin Auton Res 2010;20: 11-17
19. Maurer K, Lowitsch K, Stoehr M: Evozierte Potentiale AEP-VEPSEP. Stuttgart, Enke, 1990
20. Picton TW, Hillyard SA, Krausz HI, Galambos R: Human auditory evoked potentials. 1. Evaluation of components. Electroencephalogr Clin Neurophysiol 1974;36:179-190
21. Stockard JJ, Rossiter VS: Clinical and pathologic correlates of brain stem auditory response abnormalities. Neurology 1977;27: 316-325
22. Drechsler F, Neuhauser B: Somatosensory trigeminal evoked potentials in normal subjects and in patients with trigeminal neuralgia before and after thermocoagulation of the ganglion gasseri. Electromyogr Clin Neurophysiol 1986;26:315-326
23. Benninghoff A, Drenckhahn D: Anatomie, Makroskopische Anatomie, Embryologie und Histologie des Menschen, Band 2: Herz- Kreislauf-System, Lymphatisches System, Endokrine Drusen, Nervensystem, Sinnesorgane, Haut. Munchen, Urban & Fischer, 1994
24. Ventureyra EC: Transcutaneous vagus nerve stimulation for partial onset seizure therapy: A new concept. Childs Nerv Syst 2000;16: 101-102
25. Fallgatter AJ, Neuhauser B, Herrmann MJ, Ehlis AC, Wagener A, Scheuerpflug P, Reiners K, Riederer P: Far field potentials from the brain stem after transcutaneous vagus nerve stimulation. J Neural Transm 2003;110: 1437-1443
26. Fallgatter AJ, Ehlis AC, Ringel TM, Herrmann MJ: Age effect on far field potentials from the brain stem after transcutaneous vagus nerve stimulation. Int Psychophysiol 2005;56:37-43
27. Polak T, Ehlis AC, Langer JB, Plichta MM, Metzger F, Ringel TM, Fallgatter AJ: Noninvasive measurement of vagus activity in the brainstem-a methodological progress towards earlier diagnosis of dementias? J Neural Transm 2007;114:613-619
28. Polak T, Markulin F, Ehlis AC, Metzger F, Langer JB, Ringel TM, Fallgatter AJ: Auricular vagus somatosensory evoked potentials in vascular dementia. J Neural Transm 2009; 116:473-477
29. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988;24:641-652
30. Jasper HH: The ten-twenty electrode system of the International Federation. Electroencephalogr Clin Neurophysiol 1958;10: 371-375
31. Charter RA: A breakdown of reliability coefficients by test type and reliability method, and the clinical implications of low reliability. J Gen Psychol 2003;130:290-304